Details of the Drug
General Information of Drug (ID: DM7A50Z)
Drug Name |
1-Cyclohexylidenethiosemicarbazide
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
(cyclohexylideneamino)thiourea; Cyclohexanone thiosemicarbazone; 5351-77-9; Cyclohexanone, thiosemicarbazone; 1-Cyclohexylidenethiosemicarbazide; 2-cyclohexylidenehydrazinecarbothioamide; Hydrazinecarbothioamide, 2-cyclohexylidene-; CHEMBL510328; amino[(cyclohexylideneazamethyl)amino]methane-1-thione; AC1MD1GF; Thiosemicarbazonecyclohexanone; SCHEMBL941085; Thiosemicarbazone, cyclohexanone; NSC717; CTK1H1977; DTXSID20385240; NSC-717; MolPort-000-248-718; GYRDZVHNPFBIST-UHFFFAOYSA-N; HMS1577F04; ZINC5413245; SBB041170
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 171.27 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | 0.8 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 1 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 2 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 2 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
The Studied Disease | Discovery agent | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||